Jonathan Lambert

1.3k total citations
25 papers, 235 citations indexed

About

Jonathan Lambert is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jonathan Lambert has authored 25 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Jonathan Lambert's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Eosinophilic Disorders and Syndromes (8 papers). Jonathan Lambert is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Eosinophilic Disorders and Syndromes (8 papers). Jonathan Lambert collaborates with scholars based in United Kingdom, Australia and United States. Jonathan Lambert's co-authors include Steve Austin, David C. Linch, Rosemary E. Gale, Tamara Everington, Kirsty Thomson, Karl S. Peggs, Emma Morris, Christopher McNamara, Adele K. Fielding and Ronjon Chakraverty and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jonathan Lambert

23 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Lambert United Kingdom 9 115 74 69 65 61 25 235
Melania Carlisi Italy 10 94 0.8× 32 0.4× 105 1.5× 74 1.1× 68 1.1× 38 268
Catia Bigazzi Italy 11 184 1.6× 148 2.0× 181 2.6× 85 1.3× 121 2.0× 16 368
Guy Cantin Canada 9 79 0.7× 56 0.8× 159 2.3× 29 0.4× 97 1.6× 23 276
Vít Campr Czechia 10 121 1.1× 210 2.8× 81 1.2× 39 0.6× 147 2.4× 46 328
А. М. Ковригина Russia 7 84 0.7× 93 1.3× 69 1.0× 36 0.6× 118 1.9× 145 264
T. Tison Italy 8 133 1.2× 79 1.1× 109 1.6× 27 0.4× 16 0.3× 19 281
C. Little United States 6 215 1.9× 87 1.2× 318 4.6× 35 0.5× 80 1.3× 9 443
Angela Amendola Italy 8 211 1.8× 75 1.0× 291 4.2× 111 1.7× 21 0.3× 11 435
Amie Fonder United States 8 194 1.7× 110 1.5× 112 1.6× 81 1.2× 63 1.0× 31 291
Stefano Fiori Italy 9 50 0.4× 81 1.1× 40 0.6× 55 0.8× 91 1.5× 30 258

Countries citing papers authored by Jonathan Lambert

Since Specialization
Citations

This map shows the geographic impact of Jonathan Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lambert more than expected).

Fields of papers citing papers by Jonathan Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lambert. The network helps show where Jonathan Lambert may publish in the future.

Co-authorship network of co-authors of Jonathan Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Lambert. A scholar is included among the top collaborators of Jonathan Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Lambert. Jonathan Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blombery, Piers, Vahid Pazhakh, Adriana S. Albuquerque, et al.. (2023). Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi‐organ autoimmunity. SHILAP Revista de lepidopterología. 4(2). 463–469. 8 indexed citations
2.
Eyre, Toby A., Mark Bishton, Rory McCulloch, et al.. (2023). Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology. 204(1). 108–126. 10 indexed citations
3.
4.
5.
Lambert, Jonathan, et al.. (2022). Myeloproliferative neoplasms in adolescents and young adults. Best Practice & Research Clinical Haematology. 35(2). 101374–101374. 4 indexed citations
6.
Saunders, Christopher J., Chandan Saha, Priya Sriskandarajah, et al.. (2022). The Use of Avapritinib in Advanced Systemic Mastocytosis: Report of an Open-Label Compassionate Use Program in the United Kingdom. Blood. 140(Supplement 1). 3976–3977.
7.
Efthymiou, Maria, et al.. (2021). Coexistent antiphospholipid syndrome and myeloproliferative neoplasm. Lupus. 30(9). 1502–1508. 2 indexed citations
8.
Wilson, Andrew J., et al.. (2021). Single Centre Analysis of JAK2 V617F and Exon 12 Negative Idiopathic Erythrocytosis. Blood. 138(Supplement 1). 4620–4620. 2 indexed citations
9.
McMillan, Annabel, Paul Humphries, Jonathan Lambert, et al.. (2020). Brentuximab vedotin plus bendamustine in relapsed and refractory classical Hodgkin lymphoma in children, adolescents and young adults: a single centre experience. Klinische Pädiatrie. 1 indexed citations
10.
McCulloch, Rory, Carlo Visco, Rebecca Frewin, et al.. (2019). R-BAC Maintains High Response Rate in Mantle Cell Lymphoma Following Relapse on BTK Inhibitor Therapy. Blood. 134(Supplement_1). 3989–3989. 4 indexed citations
11.
Patel, Ami B., Emilie Leroy, Soo Jin Kim, et al.. (2019). JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera. Blood. 134(26). 2388–2398. 21 indexed citations
12.
Lambert, Jonathan, Derek Burke, Simon Heales, & Sujith Samarasinghe. (2018). 044 Establishing an asparaginase monitoring assay to inform continuous care of patients with acute lymphoblastic leukaemia. A18.1–A18.
13.
Ardeshna, Kirit M., Kate Cwynarski, David C. Linch, et al.. (2017). Evaluation of the Safety and Tolerability of Rapid Infusion of Biosimilar Rituximab Truxima® — the University College London Hospitals (UCLH) Experience. Blood. 130. 3387–3387. 3 indexed citations
14.
McKay, Pam, Patrick Fielding, Eve Gallop‐Evans, et al.. (2015). Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma. British Journal of Haematology. 172(1). 32–43. 17 indexed citations
15.
Mannu, Gurdeep, Jonathan Lambert, Joao H. Bettencourt‐Silva, et al.. (2014). The clinical utility of Multiplate analyser measurement in platelet function testing following stroke and transient ischaemic attack. European Journal Of Haematology. 94(2). 138–144. 12 indexed citations
16.
Allen, Christopher, Jonathan Lambert, David C. Linch, & Rosemary E. Gale. (2014). X chromosome inactivation analysis reveals a difference in the biology of ET patients with JAK2 and CALR mutations. Blood. 124(13). 2091–2093. 7 indexed citations
17.
Lambert, Jonathan, Jamshed Bomanji, Karl S. Peggs, et al.. (2010). Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma. Blood. 115(14). 2763–2768. 45 indexed citations
18.
Lambert, Jonathan, Tamara Everington, David C. Linch, & Rosemary E. Gale. (2009). In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm. Blood. 114(14). 3018–3023. 29 indexed citations
19.
Lambert, Jonathan, Rosemary E. Gale, & David C. Linch. (2009). The production of JAK2 wild‐type platelets is not downregulated in patients with JAK2 V617F mutant‐positive essential thrombocythaemia. British Journal of Haematology. 145(1). 128–130. 10 indexed citations
20.
Austin, Steve & Jonathan Lambert. (2008). The JAK2V617F mutation and thrombosis. British Journal of Haematology. 143(3). 307–320. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melania Carlisi Breakdown of academic impact, for papers by Catia Bigazzi Breakdown of academic impact, for papers by Guy Cantin Breakdown of academic impact, for papers by Vít Campr Breakdown of academic impact, for papers by А. М. Ковригина Breakdown of academic impact, for papers by T. Tison Breakdown of academic impact, for papers by C. Little Breakdown of academic impact, for papers by Angela Amendola Breakdown of academic impact, for papers by Amie Fonder Breakdown of academic impact, for papers by Stefano Fiori
Rankless by CCL
2026